ESD, Esophageal Stricture and steroid

**ESD (Endoscopic Submucosal Dissection):**

Endoscopic Submucosal Dissection (ESD) is a minimally invasive endoscopic procedure used to treat superficial esophageal cancer. It allows for the precise removal of cancerous lesions while preserving the surrounding healthy tissue. ESD has become the standard treatment for early-stage esophageal cancer due to its favorable outcomes, such as reduced complications and improved prognosis when compared to more invasive surgical options. However, despite its advantages, one of the major challenges following ESD is the development of **esophageal strictures**, particularly after extensive or circumferential ESD (cESD).

---

**Esophageal Stricture After ESD:**

An esophageal stricture refers to a narrowing of the esophagus, which can lead to difficulty swallowing (dysphagia). This complication is most common after large or circumferential resections during ESD, as the wound healing process often leads to fibrotic scar tissue formation and contraction of the esophageal wall. Patients with esophageal strictures can experience significant discomfort, reduced quality of life, and may require multiple interventions, such as endoscopic balloon dilations, to manage the condition.

Preventing esophageal strictures is a critical concern in patients undergoing cESD, as it directly impacts their recovery and long-term outcomes. Various strategies have been explored to reduce the risk of stricture formation, with steroid therapy being one of the most effective approaches.

---

**Role of Steroids in Preventing Esophageal Stricture:**

Steroids, such as **triamcinolone acetonide (TA)** and **oral prednisone**, are used to prevent esophageal stricture formation by reducing inflammation and inhibiting the excessive production of fibrotic tissue during the healing process. Steroids help modulate the immune response and minimize the risk of scar tissue formation that leads to esophageal narrowing.

Two main steroid-based approaches are commonly used:

1. **Combined Steroid Therapy (CST):**

This approach involves injecting triamcinolone acetonide (TA) directly into the esophageal wall immediately after cESD, followed by a prolonged course of oral prednisone. CST has shown effectiveness in reducing stricture rates, but it is not always sufficient, especially in cases of extensive resections.

2. **Submucosal Steroid Preinjection Strategy (SSPS):**

SSPS is a novel approach where triamcinolone acetonide is pre-injected into the submucosal layer of the esophagus before cESD, creating a "steroid water cushion" to reduce trauma during the procedure. Additional steroid injections are administered postoperatively to further suppress inflammation and fibrosis. SSPS has demonstrated promising clinical outcomes, with better prevention of esophageal strictures compared to CST.

---

**Key Clinical Outcomes of Steroid Use:**

Steroid therapy, whether CST or SSPS, aims to achieve the following outcomes:

• **Reduced stricture rates:** Lower incidence of esophageal narrowing and dysphagia.
• **Improved swallowing ability:** Patients experience fewer difficulties in eating and drinking post-procedure.
• **Fewer endoscopic interventions:** Stricture prevention reduces the need for repeated balloon dilation sessions.
• **Shorter hospitalization and recovery time:** Effective prevention strategies minimize complications and improve overall recovery.
• **Cost-effectiveness:** Fewer complications lead to reduced medical expenses and unscheduled visits.

---

**Conclusion:**

Steroid therapy plays a crucial role in managing esophageal strictures after ESD, particularly circumferential ESD. While CST has been widely used, the novel SSPS approach shows promising results in further improving outcomes by integrating pre-procedural steroid injections. Both strategies aim to enhance patient recovery, reduce complications, and improve quality of life following treatment for superficial esophageal cancer.